All Posts

Proseek Bio is pleased to announce that our research has been accepted for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, one of the world's leading forums for oncology research, clinical practice, and innovation. The accepted abstract, published in the Journal of Clinical Oncology, reports findings from an international collaboration between Australia and Malaysia. The study highlights the successful completion of an inter-laboratory de

We’re proud to announce that Proseek Bio has been selected to join the 2026 BioTools Innovator cohort; a globally competitive accelerator program spotlighting the most promising companies advancing life science tools and diagnostics. Chosen from a pool of nearly 550 applicants, Proseek Bio is one of just 30 companies selected, placing it among the top tier of emerging innovators in the field. This milestone reflects both the strength of our platform and the growing recognitio

Proseek Bio has been selected for the UNSW Global Landing Pads program, supporting our upcoming expansion into the United States.